ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
ATAI Life Sciences NV

ATAI Life Sciences NV (9VC)

1.1385
-0.017
( -1.47% )
Updated: 07:14:41
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.1385
Bid
1.147
Ask
1.1915
Volume
230
1.1385 Day's Range 1.1855
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.1555
Open
1.1855
Last Trade
8
@
1.1385
Last Trade Time
04:31:42
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
167,802,396
Dividend Yield
-
PE Ratio
-5.05
Earnings Per Share (EPS)
-0.24
Revenue
314k
Net Profit
-40.22M

About ATAI Life Sciences NV

Sector
Intermediate Care Facilities
Industry
Intermediate Care Facilities
Website
Headquarters
Berlin, Deu
Founded
-
ATAI Life Sciences NV is listed in the Intermediate Care Facilities sector of the Tradegate (DE) with ticker 9VC. The last closing price for ATAI Life Sciences NV was 1.16 €. Over the last year, ATAI Life Sciences NV shares have traded in a share price range of 0.00 € to 0.00 €.

ATAI Life Sciences NV currently has 167,802,396 shares outstanding. The market capitalization of ATAI Life Sciences NV is 193.90 € million. ATAI Life Sciences NV has a price to earnings ratio (PE ratio) of -5.05.

9VC Latest News

atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt

atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt Mehrere Wirkstoffe im...

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) Advanced multiple...

atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt

atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt NEW YORK und BERLIN, Aug. 09, 2023 (GLOBE...

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) NEW YORK and BERLIN, Aug. 08, 2023 (GLOBE NEWSWIRE) -- atai Life...

atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil

atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil NEW YORK und BERLIN, June 05, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein im klinischen...

atai Life Sciences to Participate in Upcoming June Investor Conferences

atai Life Sciences to Participate in Upcoming June Investor Conferences NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt

atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt RL-007: Erster Patient in der Phase-IIb-Studie zu RL-007 bei...

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive...

atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz

atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz NEW YORK und BERLIN, May 03, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein...

atai Life Sciences to Participate in Upcoming May Investor Conference

atai Life Sciences to Participate in Upcoming May Investor Conference NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

9VC - Frequently Asked Questions (FAQ)

What is the current ATAI Life Sciences NV share price?
The current share price of ATAI Life Sciences NV is 1.1385 €
How many ATAI Life Sciences NV shares are in issue?
ATAI Life Sciences NV has 167,802,396 shares in issue
What is the market cap of ATAI Life Sciences NV?
The market capitalisation of ATAI Life Sciences NV is EUR 193.9M
What is the 1 year trading range for ATAI Life Sciences NV share price?
ATAI Life Sciences NV has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of ATAI Life Sciences NV?
The price to earnings ratio of ATAI Life Sciences NV is -5.05
What is the cash to sales ratio of ATAI Life Sciences NV?
The cash to sales ratio of ATAI Life Sciences NV is 636.84
What is the reporting currency for ATAI Life Sciences NV?
ATAI Life Sciences NV reports financial results in USD
What is the latest annual turnover for ATAI Life Sciences NV?
The latest annual turnover of ATAI Life Sciences NV is USD 314k
What is the latest annual profit for ATAI Life Sciences NV?
The latest annual profit of ATAI Life Sciences NV is USD -40.22M
What is the registered address of ATAI Life Sciences NV?
The registered address for ATAI Life Sciences NV is WALLSTRABE 16, BERLIN, 10179
What is the ATAI Life Sciences NV website address?
The website address for ATAI Life Sciences NV is www.atai.life
Which industry sector does ATAI Life Sciences NV operate in?
ATAI Life Sciences NV operates in the INTERMEDIATE CARE FACILITIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0RARAPT Therapeutics Inc
1.34 €
(67.50%)
25.09k
E3O1Nexoptic Technology Corp
0.026 €
(40.54%)
2.84k
4XHFreeport Resources Inc
0.021 €
(40.00%)
15.14k
FWR0Yumy Candy Company Inc the
0.035 €
(40.00%)
1.6M
28W0Aston Minerals Limited
0.0075 €
(36.36%)
83.28k
WWTWater Ways Technologies Inc
0.0045 €
(-95.91%)
2.53k
8WFJackson Financial Inc
9.6113 €
(-88.65%)
52
L7C2Windfall Geotek Inc
0.0025 €
(-70.59%)
40k
QP9Atco Mining Inc
0.003 €
(-55.88%)
1.5k
0PV2Moovly Media Inc
0.002 €
(-55.56%)
500
DI6Distribuidora Internacional De Alimentacion SA
0.0169 €
(1.20%)
1.81M
JSISamhallsbyggnadsbolaget Norden AB
0.383 €
(7.61%)
1.79M
D7GNel ASA
0.249 €
(-1.03%)
1.73M
FWR0Yumy Candy Company Inc the
0.035 €
(40.00%)
1.6M
PF8European Lithium Limited
0.0202 €
(-1.94%)
1.13M

Discussion

View Full Feed
werd werd 5 minutes ago
style="color: rgba(25, 25, 25, 1); font-family: GMsans-Web-Regular, Helvetica, Arial, Verdana, sans-serif; font-size: 20px; text-align: justify; background-color: rgba(255, 255, 255, 1)""The agreements contemplate a phased transaction structure, starting with GBT acquiring 49% ownership of Nexus pro
GLTA GTCH
StonkMaster StonkMaster 5 minutes ago
He said 10x twice. Therefore 10,000%.
NWBO
Investor2014 Investor2014 5 minutes ago
I for one am very pleased with this morning's news of EMA accepting the MAA. We are now in with a real chance.
AVXL
urge2surge urge2surge 5 minutes ago
4 years and millions wasted. Zero credibility here. Why would anyone trust anything here? Most shareholders followed the "money", look what you got.
Wake up..
GMER
WeTheMarket WeTheMarket 6 minutes ago
A Christmas Fuel Cell Miracle: Plug Power and More
December 23, 2024
https://fuelcellz.com/christmas-fuel-cell-miracle/
PLUG
100lbStriper 100lbStriper 6 minutes ago
mrbiggumsworth $NLST As of December 22, 2024, the U.S. Court of Appeals for the Federal Circuit (CAFC) has docketed appeals related to Netlist’s patent infringement cases against Samsung and Micron.
• Samsung: An appeal was docketed on April 17, 2024, under case number 24-1707. ?
• M
NLST
Cpap21 Cpap21 7 minutes ago
No you don’t !!’
AVXL
x993231 x993231 7 minutes ago
I didn't read it, because I don't realy care about an email to Walter.   Putting you on iggy.

Walter trys to help and could never please everybody but the man does try and bless him for that. 

No good deed goes unpunished.

X
LWLG
Thomas@yahoo Thomas@yahoo 7 minutes ago
https://www.mdpi.com/1422-0067/25/23/12738
CVSI
Cpap21 Cpap21 8 minutes ago
There is more news coming !!!
For all the posters like investor , Kund fu, Mike, and the rest of you shorts that call this stocks POS, you may want to cover now !!! There is nothing else to say . You all swore we would never even submit !
Just sayn !!’
Now Tweet That AF !!!!
AVXL
sortagreen sortagreen 8 minutes ago
It's a basement, you moron.
Jetmek_03052 Jetmek_03052 9 minutes ago
I cannot agree with this statement:

Neither side providing new or interesting company information.

People who post factual numbers from the audited financials provide new (and interesting) evidence of DBMM's failure to perform EVERY THREE MONTHS.

As far a
DBMM
flipper44 flipper44 9 minutes ago
You need basic math help.

.26 x 10 = 2.60

That would be a 900% increase off a previously downward manipulated price.


2.60 would not be a 10,000 percent increase as your bad math incorrectly states.
NWBO
stockprofitter stockprofitter 10 minutes ago
Alot of people agree over a hundred #fnma

https://x.com/nicosintichakis/status/1870827265162092776?s=61&t=KEFTLxsG2C318JcOnlHS4Q
FNMA
Mojocash Mojocash 10 minutes ago
Volume down in pre market
NVNI
glenn1919 glenn1919 10 minutes ago
reli............................https://stockcharts.com/h-sc/ui?s=reli&p=W&yr=1&mn=3&dy=0&id=p96837884856
MrSteven MrSteven 11 minutes ago
BELOW MAIL WAS SENT BY LAXMI PRASAD ON 2ND DECEMBER 2024


Staff and Cash Grant Payout schedule attachment --
Our Comments
Staff Payouts
1. We have carefully balanced our capacity to make staff and shareholder payouts and meet company capital requirements
ITUP
Golden Cross Golden Cross 11 minutes ago
$ILST I think we will get a solid boost this week!
Nice new article out:
https://allcapresearch.com/f/ilst-poised-for-growth-in-cannabis-entertainment?fbclid=IwY2xjawHVZJFleHRuA2FlbQIxMAABHeoUWfrL5_3wixxhfnkJwX4eO4k_ECPrb8AOaGiSyNiLnF4eaKYyWUv_yg_aem_el9KR3CNv66gRm24Fua7Xg
ILST
knrorrel knrorrel 12 minutes ago
$WIMI moving up



$WIMI strong buy
imho



$WIMI Market cap is only about $105 million

but this quantum computing name has over $1 billion in cash or about $6 per share if you look at their profile on Yahoo Finance for
WIMI
tedpeele tedpeele 12 minutes ago
NNVC bird flu news - pre market: NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says
API NNVC
JFBroderick JFBroderick 12 minutes ago
Linkvest what are the chances of the company's biggest advocate getting a current list of shareholders/holdings to see what the distribution looks like and float lock up situation? 😇
ASII
Golden Cross Golden Cross 12 minutes ago
$ILST I think we will get a solid boost this week!
Nice new article out:
https://allcapresearch.com/f/ilst-poised-for-growth-in-cannabis-entertainment?fbclid=IwY2xjawHVZJFleHRuA2FlbQIxMAABHeoUWfrL5_3wixxhfnkJwX4eO4k_ECPrb8AOaGiSyNiLnF4eaKYyWUv_yg_aem_el9KR3CNv66gRm24Fua7Xg
ILST

Your Recent History

Delayed Upgrade Clock